Glaxosmithkline Plc (GSK)

$ 50.01
   
  • Change Today:
    $-0.04
  • 52 Week High: $60.23
  • 52 Week Low: $39.52
  • Currency: US Dollars
  • Shares Issued: 465.72m
  • Volume: 2,735,962
  • Market Cap: $23,291m
  • RiskGrade: 119

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
Brands: Lucozade, Horlicks, Ribena, Paxil, Seroxat

Key Personnel

CEO: Luke Miels
Chief Finance Officer: Julie Brown
Independent Non-Executive Director: Anne Beal
Independent Non-Executive Director: Harry (Hal) C. Dietz
Independent Non-Executive Director: Vishal Sikka
Independent Non-Executive Director: Elizabeth (Liz) McKee Anderson
Non-Executive Chairman: Jonathan Symonds
Senior Independent Non-Executive Director: Charles Bancroft
Non-Executive Dir: Hal Barron , Wendy Becker , Jeannie Lee , Gavin Screaton, Roy Jakobs

Contact Details

Address: 79 New Oxford Street, London, United Kingdom, WC1A 1DG
Phone: +44 (0)20 8047 5000
Website: http://www.gsk.com/en-gb/

Listings

Overseas Listings: BATSLON:GSKL, LSE:GSK
ISIN: US37733W2044

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency US Dollars
Share Price $ 50.01
Change Today $ -0.04
% Change -0.08 %
52 Week High $60.23
52 Week Low $39.52
Volume 2,735,962
Shares Issued 465.72m
Market Cap $23,291m
RiskGrade 119

Trades for 15-Sep-2026

Time Volume / Share Price
16:00 263,015 @ $50.01
16:00 300 @ $49.98
16:00 1,396 @ $49.99
16:00 2,978 @ $49.99
16:00 200 @ $49.99

GSK Key Personnel

CEO Luke Miels

Top of Page